{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:19:38Z","timestamp":1778815178701,"version":"3.51.4"},"reference-count":77,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Nonradiographic axial spondyloarthritis (nr-axSpA) represents a distinct phenotype within the spectrum of axial spondyloarthritis (axSpA), which is characterized by a range of clinical manifestations. Despite a high disease burden that is comparable to ankylosing spondylitis (also known as radiographic axSpA), there is an unmet need to recognize and effectively manage patients with active nr-axSpA.<\/jats:p>\n            <jats:p>A targeted literature search was conducted in OVID (MEDLINE and Embase databases) to identify articles on nr-axSpA, including its definition, demographics, epidemiology, burden, diagnosis, clinical presentation, and treatment guidelines.<\/jats:p>\n            <jats:p>The lack of adequate epidemiological data and incomplete understanding of nr-axSpA among rheumatologists and nonrheumatologists contributes to delayed referrals and diagnosis. This delay results in a substantial burden on patients, physically and psychologically, and the healthcare system. Targeted therapies, such as biologics, including inhibitors of tumor necrosis factor or interleukin-17A, have been approved and utilized for the management of nr-axSpA, and other novel therapeutics with different mechanisms of action are in development. Raising awareness among US internists regarding the prevalence of nr-axSpA, disease burden, clinical presentation, diagnostic tools, and available treatments is important for improved disease management.<\/jats:p>\n            <jats:p>Future clinical investigations focusing on the development of markers that aid early diagnosis and predict treatment response may also improve the management of nr-axSpA. This review provides an overview of nr-axSpA with the aim of raising awareness of the disease among US internists, with an overarching goal to contribute toward the improved recognition and timely referral of these patients to rheumatologists for diagnosis and management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029063","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T14:34:18Z","timestamp":1651070058000},"page":"e29063","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease"],"prefix":"10.1097","volume":"101","author":[{"given":"Marina","family":"Magrey","sequence":"first","affiliation":[{"name":"Case Western Reserve University School of Medicine at MetroHealth Medical Center, Department of Medicine, Division of Rheumatology, Cleveland, OH"},{"name":"University Hospitals Cleveland Medical Center School of Medicine, Division of Rheumatology, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Schwartzman","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College, Division of Rheumatology, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"de Peyrecave","sequence":"additional","affiliation":[{"name":"UCB Pharma, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor S.","family":"Sloan","sequence":"additional","affiliation":[{"name":"Sheng Consulting LLC, Flemington, NJ"},{"name":"Rutgers Robert Wood Johnson Medical School, Division of Rheumatology and Connective Tissue Research, New Brunswick, NJ"},{"name":"The Peace Corps, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7716-2727","authenticated-orcid":false,"given":"Jeffrey L.","family":"Stark","sequence":"additional","affiliation":[{"name":"UCB Pharma, Smyrna, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.berh.2014.10.007","article-title":"The concept of spondyloarthritis: where are we now?","volume":"28","author":"Garg","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"(Suppl 2)","key":"R3-20250504","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis International Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"03","DOI":"10.1136\/annrheumdis-2017-211734","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R5-20250504","first-page":"10","article-title":"Ankylosing spondylitis","volume":"27","author":"Jimenea","year":"1979","journal-title":"Henry Ford Hosp Med J"},{"issue":"(4 Suppl 55)","key":"R6-20250504","first-page":"S3","article-title":"How did ankylosing spondylitis become a separate disease?","volume":"27","author":"Benedek","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/art.1780280107","article-title":"Spondylitic disease without radiologic evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients","volume":"28","author":"Khan","year":"1985","journal-title":"Arthritis Rheum"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/art.1780270301","article-title":"The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s41927-019-0086-3","article-title":"Trends in diagnostic prevalence and treatment patterns of male and female ankylosing spondylitis patients in the United States, 2006\u20132016","volume":"3","author":"Walsh","year":"2019","journal-title":"BMC Rheumatol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.mayocp.2020.02.007","article-title":"Recognizing axial spondyloarthritis: a guide for primary care","volume":"95","author":"Magrey","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/acr.21994","article-title":"Prevalence of axial SpA in US rheumatology practices: assessment of ASAS criteria vs. rheumatology expert clinical diagnosis","volume":"65","author":"Strand","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/MAJ.0b013e318294457f","article-title":"The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States","volume":"345","author":"Reveille","year":"2013","journal-title":"Am J Med Sci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/acr.23534","article-title":"Characterization of patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis in the US-based CORRONA registry","volume":"70","author":"Mease","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/art.39612","article-title":"Frequency of axial spondyloarthritis diagnosis among patients seen by EU rheumatologists for evaluation of chronic back pain","volume":"68","author":"Deodhar","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.24483","article-title":"The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort","volume":"60","author":"Rudwaleit","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/acr.22001","article-title":"Differences between women and men with recent-onset axial spondyloarthritis: results from a prospective multicenter French cohort","volume":"65","author":"Tournadre","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/1744666X.2018.1477591","article-title":"Radiographic progression in non-radiographic axial spondyloarthritis","volume":"14","author":"Protopopov","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/art.39542","article-title":"Progression of nonradiographic axial spondyloarthritis to ankylosing spondylitis: a population-based cohort study","volume":"68","author":"Wang","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41584-020-00552-4","article-title":"Axial spondyloarthritis: concept, construct, classification and implications for therapy","volume":"17","author":"Robinson","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.semarthrit.2016.09.002","article-title":"Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritis","volume":"46","author":"Sieper","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jbspin.2019.04.006","article-title":"Structural progression in axial spondyloarthritis","volume":"87","author":"Aouad","year":"2020","journal-title":"Joint Bone Spine"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13075-019-1970-3","article-title":"Alcohol consumption as a predictor of the progression of spinal structural damage in axial spondyloarthritis: data from the Catholic Axial Spondyloarthritis COhort (CASCO)","volume":"21","author":"Min","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/art.38776","article-title":"The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis International Society in response to the US food and drug administration's comments and concerns","volume":"66","author":"Deodhar","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.semarthrit.2020.05.005","article-title":"Understanding differences between men and women with axial spondyloarthritis","volume":"50","author":"Wright","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/acr.21688","article-title":"Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?","volume":"64","author":"Kiltz","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"A386","DOI":"10.1016\/j.jval.2014.08.2648","article-title":"Quality of life in patients with axial spondyloarthritis in clinical practice in Sweden: baseline results from a longitudinal study","volume":"17","author":"Jacobsson","year":"2014","journal-title":"Value Health"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","article-title":"Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study","volume":"75","author":"Molt\u00f3","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3899\/jrheum.180538","article-title":"Increased risk of hypertension associated with spondyloarthritis disease duration: results from the ASAS-COMOSPA study","volume":"46","author":"Derakhshan","year":"2019","journal-title":"J Rheumatol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"e024713","DOI":"10.1136\/bmjopen-2018-024713","article-title":"Cross-sectional study of patients with axial spondyloarthritis fulfilling imaging arm of ASAS classification criteria: baseline clinical characteristics and subset differences in a single-centre cohort","volume":"9","author":"Bubov\u00e1","year":"2019","journal-title":"BMJ Open"},{"key":"R32-20250504","article-title":"Long term outcome of total hip replacement in patients with ankylosing spondylitis","author":"Lizarraga"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00296-020-04621-5","article-title":"The prevalence of fibromyalgia in axial spondyloarthritis","volume":"40","author":"Jones","year":"2020","journal-title":"Rheumatol Int"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/art.40185","article-title":"Co-occurrence and characteristics of patients with axial spondyloarthritis who meet criteria for fibromyalgia: results from a UK national register","volume":"69","author":"Macfarlane","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/1557988312436872","article-title":"Are there gender differences in quality of life and symptomatology between fibromyalgia patients?","volume":"6","author":"Aparicio","year":"2012","journal-title":"Am J Mens Health"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13075-018-1644-6","article-title":"The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis","volume":"20","author":"Zhao","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10067-018-4397-3","article-title":"Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities","volume":"38","author":"Danve","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.2003.011247","article-title":"How to diagnose axial spondyloarthritis early","volume":"63","author":"Rudwaleit","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/acr2.11179","article-title":"Understanding barriers in the pathway to diagnosis of ankylosing spondylitis: results from a US survey of 1690 physicians from 10 specialties","author":"Magrey","year":"2020","journal-title":"ACR Open Rheumatol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/annrheumdis-2012-201777","article-title":"Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study","volume":"72","author":"Sieper","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/annrheumdis-2014-207151","article-title":"Development of an ASAS-endorsed recommendation for the early referral of patients with a suspicion of axial spondyloarthritis","volume":"74","author":"Poddubnyy","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"e000389","DOI":"10.1136\/rmdopen-2016-000389","article-title":"Evaluation of multiple referral strategies for axial spondyloarthritis in the SPondyloArthritis Caught Early (SPACE) cohort","volume":"3","author":"Abawi","year":"2017","journal-title":"RMD Open"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1136\/ard.2011.152975","article-title":"HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis","volume":"70","author":"Chung","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1097\/RHU.0000000000001575","article-title":"Clinical manifestations and diagnosis of axial spondyloarthritis","volume":"27","author":"Walsh","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10067-015-2949-3","article-title":"Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis","volume":"34","author":"Reveille","year":"2015","journal-title":"Clin Rheumatol"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3899\/jrheum.130588","article-title":"Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases?","volume":"40","author":"Wallis","year":"2013","journal-title":"J Rheumatol"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/rheumatology\/kex081","article-title":"Non-radiographic axial spondyloarthritis patients without initial evidence of inflammation may develop objective inflammation over time","volume":"56","author":"Baraliakos","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"e000283","DOI":"10.1136\/rmdopen-2016-000283","article-title":"Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis? Data from the SPACE cohort","volume":"2","author":"Vargas","year":"2016","journal-title":"RMD Open"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2014-206971","article-title":"EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice","volume":"74","author":"Mandl","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40744-019-0146-6","article-title":"Non-radiographic axial spondyloarthritis (nr-axspa): advances in classification, imaging and therapy","volume":"6","author":"Robinson","year":"2019","journal-title":"Rheumatol Ther"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1136\/annrheumdis-2015-208642","article-title":"Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group","volume":"75","author":"Lambert","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/art.40475","article-title":"Magnetic resonance imaging of the sacroiliac joints indicating sacroiliitis according to the Assessment of Spondyloarthritis International Society definition in healthy individuals, runners, and women with postpartum back pain","volume":"70","author":"de Winter","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/art.40429","article-title":"Frequency and anatomic distribution of magnetic resonance imaging features in the sacroiliac joints of young athletes: exploring \u201cbackground noise\u201d toward a data-driven definition of sacroiliitis in early spondyloarthritis","volume":"70","author":"Weber","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/art.39549","article-title":"Editorial: Sacroiliac joint magnetic resonance imaging in the diagnosis of axial spondyloarthritis: \u201ca tiny bit of white on two consecutive slices\u201d may be objective, but not specific","volume":"68","author":"Deodhar","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/rheumatology\/kez173","article-title":"Recommendations for acquisition and interpretation of MRI of the spine and sacroiliac joints in the diagnosis of axial spondyloarthritis in the UK","volume":"58","author":"Bray","year":"2019","journal-title":"Rheumatology"},{"issue":"(Suppl 4)","key":"R56-20250504","doi-asserted-by":"crossref","first-page":"iv25","DOI":"10.1093\/rheumatology\/keaa472","article-title":"Axial spondyloarthritis 10\u200ayears on: still looking for the lost tribe","volume":"59","author":"Barnett","year":"2020","journal-title":"Rheumatology"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fmed.2018.00106","article-title":"The role of imaging in diagnosing axial spondyloarthritis","volume":"5","author":"Khmelinskii","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00296-018-4130-1","article-title":"Radiologic approach to axial spondyloarthritis: where are we now and where are we heading?","volume":"38","author":"Kucyba\u0142a","year":"2018","journal-title":"Rheumatol Int"},{"key":"R59-20250504","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3899\/jrheum.091216","article-title":"Limited diagnostic value of unilateral sacroiliitis in scintigraphy in assessing axial spondyloarthritis","volume":"37","author":"Song","year":"2010","journal-title":"J Rheumatol"},{"key":"R60-20250504","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/annrheumdis-2021-220136","article-title":"Choose wisely: imaging for diagnosis of axial spondyloarthritis","volume":"81","author":"Diekhoff","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R61-20250504","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/ard.2007.083089","article-title":"The diagnostic value of scintigraphy in assessing sacroiliitis in ankylosing spondylitis: a systematic literature research","volume":"67","author":"Song","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R62-20250504","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s10067-016-3231-z","article-title":"Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delay","volume":"35","author":"Deodhar","year":"2016","journal-title":"Clin Rheumatol"},{"key":"R63-20250504","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/art.41042","article-title":"2019 update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network Recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"71","author":"Ward","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R64-20250504","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R65-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1007\/s40744-019-00170-x","article-title":"New insights in physical therapy and rehabilitation in axial spondyloarthritis: a review","volume":"6","author":"Perrotta","year":"2019","journal-title":"Rheumatol Ther"},{"key":"R66-20250504","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13075-016-1180-1","article-title":"Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis","volume":"18","author":"Levitova","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"R67-20250504","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/rheumatology\/kew367","article-title":"Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis","volume":"56","author":"Baraliakos","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R68-20250504","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/annrheumdis-2015-207897","article-title":"Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2\u200ayears on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS)","volume":"75","author":"Sieper","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R69-20250504","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/annrheumdis-2012-203201","article-title":"Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, part 1","volume":"73","author":"Sieper","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R70-20250504","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/annrheumdis-2012-201766","article-title":"Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)","volume":"72","author":"Sieper","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R71-20250504","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/art.38721","article-title":"Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"66","author":"Dougados","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R72-20250504","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/art.39257","article-title":"A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis","volume":"67","author":"Sieper","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R73-20250504","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/rheumatology\/kex174","article-title":"Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA","volume":"56","author":"van der Heijde","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R74-20250504","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/annrheumdis-2017-212377","article-title":"Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial","volume":"77","author":"van der Heijde","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R75-20250504","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.40866","article-title":"A fifty-two-week, randomized, placebo-controlled trial of certolizumab pegol in nonradiographic axial spondyloarthritis","volume":"71","author":"Deodhar","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R76-20250504","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(19)32971-X","article-title":"Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial","volume":"395","author":"Deodhar","year":"2020","journal-title":"Lancet"},{"key":"R77-20250504","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/art.41477","article-title":"Improvement of signs and symptoms of nonradiographic axial spondyloarthritis in patients treated with secukinumab: primary results of a randomized, placebo-controlled phase iii study","volume":"73","author":"Deodhar","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R79-20250504","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/annrheumdis-2017-212196","article-title":"Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study","volume":"77","author":"Mariette","year":"2018","journal-title":"Ann Rheum Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:07:31Z","timestamp":1746328051000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029063"}},"subtitle":["A narrative review"],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":77,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029063","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"assertion":[{"value":"2021-11-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}